Background Aortogenic stroke is an important subtype of embolic strokes, yet lacks a diagnostic method for proactive ...

Purpose Sotatercept, an activin signalling inhibitor approved in March 2024 for pulmonary arterial hypertension (PAH), ...

Background Biochemical markers of inflammation, coagulation and myocardial stress have been associated with both prevalent ...

Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...

Background Cardiac MR (CMR) provides a comprehensive assessment of pericardial structure, tissue characteristics and constriction-related haemodynamics, making it an excellent tool for assessing the ...

Background Sudden cardiac death (SCD) is a common cause of cardiovascular mortality, often triggered by ventricular ...

Background The aim of the study was to estimate the sex-specific prevalence and incidence of atrial fibrillation or flutter ...

Aim In the UK, pharmacological management of patients with heart failure (HF) occurs predominantly in general practice. Using ...

Background Postoperative cerebral infarction following coronary artery bypass grafting (CABG) for multivessel coronary artery ...

Introduction Despite valvular heart disease (VHD) being a major contributor to cardiovascular health issues globally, limited epidemiological data exist for Malaysia. Objective To examine the ...

Aim Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) have a direct cardiac effect that is independent of their glucose-lowering renal effect. We investigated the relation between SGLT-2is and ...

Because serum magnesium does not reflect intracellular magnesium, the latter making up more than 99% of total body magnesium, most cases of magnesium deficiency are undiagnosed. Furthermore, because ...